At Innoplexus, we are disrupting the traditional, manual processes of how data intelligence and analytics is generated and consumed in Pharmaceutical, Banking and Financial Services industry. Our products, powered by AI and Blockchain technology help enterprises to gain broader, deeper, and faster insights from the avalanche of structured and unstructured data. We help companies in discovering new opportunities and answers to the questions hidden in disconnected data, and help them in making empowered, inspired & faster decisions.”
Technology Spotlight Partners
Over the next 10 years, biotech will fundamentally rewrite the way we live. From medicine and energy, to food and agriculture, to materials and textiles, biotech is radically affecting and improving society's most crucial industries.
The researchers developing these innovations are applying the most cutting-edge scientific techniques, from CAR-T immunotherapy to CRISPR/Cas9 gene editing. But they have to use outdated tools, work through inefficient processes, and base decisions on incomplete data.
Benchling’s mission is to be the platform that drives the industrialization of this new biotech economy.
By enabling the rapid development of new scientific techniques and empowering faster and smarter decision-making, Benchling will give scientists the tools they need to bring all of us into a bright future.
CDD provides a modern approach to drug discovery research informatics trusted globally by thousands of leading researchers. The CDD Vault is a hosted biological and chemical database that securely manages your private and external data.
Genialis is passionate about improving healthcare outcomes by innovating at the nexus of big data, machine learning, and expert human engagement. Our interdisciplinary team applies its decades of experience in biomedical research, artificial intelligence, bioinformatics and software development to critical unmet needs along the journey from drug discovery to precision medicine. We build software and digital disease models, but most importantly, we build lasting relationships with industry leading therapeutics and clinical scientists.
Seven Bridges is the leading biomedical data company, specializing in software and data analytics to drive public and private healthcare research.
We deliver end-to-end bioinformatic solutions — including access to datasets, analytic workflows and algorithms, cloud-computing infrastructure, and scientific support — that speed the path from raw experimental data to new treatments and diagnostics.
Use Seven Bridges to discover more from your genomic and clinical data with immediate access to more public datasets and bioinformatics tools than anywhere else.
Innovation Showcase Partner
Founded in 2015, BioSymetrics is a biomedical AI company that’s empowering healthcare and R&D innovation with leading data science expertise. Our work is focused on making end-to-end machine learning accessible to scientists and life sciences organizations.
The BioSymetrics technology offering is a SaaS-based biomedical Machine Learning (ML) platform, Augusta™, that enables customers to perform automated ML and data pre-processing. Augusta’s automated iteration framework addresses the step in ML that is the most time consuming and error-prone, that of cleaning and pre-processing unstructured data for analysis.
BioSymetrics serves biopharmaceutical, precision medicine, and technology companies, and hospitals and health systems. Augusta™ performs member-level predictive analytics on many kinds of R&D and healthcare data.
DNAnexus provides a global network for sharing and management of genomic data and tools to accelerate genomics. The DNAnexus cloud-based platform is optimized to address the challenges of security, scalability, and collaboration, for organizations that are pursuing genomic-based approaches to health, in the clinic and in the research lab. The DNAnexus team is made up of experts in computational biology and cloud computing who work with organizations to tackle some of the most exciting opportunities in human health, making it easier—and in many cases feasible—to work with genomic data. With DNAnexus, organizations can stay a step ahead in leveraging genomics to achieve their goals. The future of human health is in genomics. DNAnexus brings it all together.
Schrodinger improve human health and quality of life through development, distribution, and application of advanced computational methods that transform the way scientists design therapeutics and materials.
By building and deploying breakthrough scientific software solutions, providing software and services to our clients, and forming collaborations and partnerships, Schrodinger accelerate research and development activities, reduce costs, and make novel discoveries that might otherwise not be possible.
nQ Medical is a machine learning company with a computational biomarker that passively collects user data from personal devices to support disease management of neurodegenerative disorders, eg, Alzheimer’s, Parkinson’s, ALS, MS, et al. Its artificial intelligence technology has been proven in four years of clinical trials at MIT to substantially change the way disease is managed for a wide range of neuromotor and neurocognitive disorders. nQ focuses on analysis of user interaction with common electronic devices to capture functional decline related to neurodegenerative disorders. The fine control of typing and touch screen kinematics together with the frequent use of electronic devices allows for precise monitoring of small changes in neurodegeneration that frequently go unnoticed by clinicians. It also allows for 24/7, passive, data collection, thus eliminating the adherence problems plaguing most therapeutic interventions.
Our mission is to revolutionise scientific process and data management in order to accelerate discoveries and drive higher quality of healthcare. Our end-to-end solutions and services yield efficiencies that enable researchers to make more breakthroughs and healthcare companies to provide superior care.
Exploristics specialises in developing and applying innovative analytics solutions that let us – and our clients – derive more information from data collected in life sciences research, clinical trials and electronic health records.
We have considerable experience of drug discovery and clinical development within the pharmaceutical industry and pride ourselves on offering uniquely high service levels to all our clients.
Tessella, Altran World Class Center for Analytics, is an international data science, analytics and AI technology consulting services provider. We partner with our clients to build exceptional digital business capabilities that connect people and data intelligently. With nearly four decades of hard-won experience across a range of industries, we are uniquely prepared for your toughest challenges.
Our mission is clear, we want to use our unique capabilities to tackle the health challenges facing the world of today as well as the world of tomorrow and, ultimately, improve the lives of billions of people around the globe.
Trying to ACCESS DECISION-MAKERS who are LOOKING FOR NEW TECHNOLOGY AND SOLUTIONS?
The reality for solution providers is stark. Senior decision makers and influencers spend less than 2% of their time engaging with solution providers - less than one hour per week. The cost of securing their time can be huge.
D4 will gather senior pharma/biotech decision makers and influencers all in one place, where the entire context of the meeting is navigating new territory, overcoming challenges and identifying new solutions and partners. This allows for focused and sustained solution-driven conversations that are significantly more likely to lead to closing business.
BENEFITS OF PARTNERING
This conference will provide partners with opportunities to gather buyer and product intelligence, demonstrate trust and value, and generate highly relevant leads through the forming of new relationships.
GET ACCESS: Open the doors of new, previously impenetrable, prospects by demonstrating value and building trust.
BUILD TRUST: Build and develop trusted relationships with key people in the target market.
GENERATE LEADS: Grow your sales pipeline and gather information not readily available to competitors.
STEER YOUR R&D. Gather actionable intelligence that will influence your R&D by understanding market needs.
REFINE YOUR SALES & MARKETING APPROACH: Gain an in-depth understanding of what buyers and influencers look for when evaluating new technology and making purchasing decisions.
THOUGHT LEADERSHIP: Get unique access to end-users who are shaping the future.
LONGEVITY AND EXTENDED BENEFITS: Further exposure to the wider market through the post-meeting report.
If you are interested for more details on available packages or would like to discuss sponsorship opportunities for this event, please don’t hesitate to contact us.